ARS:年度报告
04/26 15:15 (美东)
PRE 14A:并购重组委托声明
04/22 16:37 (美东)
10-K/A:年度报表(修正版)
04/22 16:32 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 8-K:重大事件
04/03 16:03 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 10-K:年度报表
03/28 06:49 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 8-K:肿瘤研究所公布2023年第四季度和全年财务业绩和2024年指导
03/27 16:10 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/30 19:08 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/26 19:20 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/23 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 144:拟议出售证券
01/19 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%)等
01/02 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
01/02 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 BARASCH RICHARD A
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Hively Brad
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Johnson Karen Marie
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Kaushal Mohit
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Ling Gabriel
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 McGeorge Anne
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 O'Meara Maeve
2023/12/28 00:00 (美东)
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Pacala Mark L
2023/12/28 00:00 (美东)
暂无数据
暂无数据